Want to see AME full AI Analyst Report?
Top Page
Ametek
(NYSE:AME)
Select Model
Select Model
Rating:78Outperform
Price Target:
$276.00
â–²(12.56% Upside)
Action:Reiterated
Date:08/27/26
AME scores well primarily on strong financial performance (durable margins, low leverage, solid free cash flow) and a highly positive earnings update with raised guidance and record orders/backlog. Offsetting this are a weaker near-term technical backdrop and a relatively expensive valuation, while recent corporate actions are supportive but add integration and financing risk due to the large Indicor acquisition.
Positive Factors
Orders and Backlog Strength
Record orders and a sizable backlog provide strong revenue visibility across the next several quarters. The 1.12 book-to-bill ratio indicates demand is replenishing faster than shipments, supporting sustained growth in specialized markets.
Negative Factors
Acquisition Integration and Financing Risk
The large Indicor acquisition increases execution complexity and financing commitments even though current leverage remains manageable. Realizing projected synergies and integrating businesses without disrupting customer service will be important to sustaining returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Orders and Backlog Strength
Record orders and a sizable backlog provide strong revenue visibility across the next several quarters. The 1.12 book-to-bill ratio indicates demand is replenishing faster than shipments, supporting sustained growth in specialized markets.
Read all positive factors
Ametek Key Performance Indicators (KPIs)
Any
Revenue by Product
Shows how much revenue each product line generates, highlighting which products are driving growth and which may need strategic adjustments.
Shows how much revenue each product line generates, highlighting which products are driving growth and which may need strategic adjustments.
Data provided by:
The Fly
The FlyAmetek (AME) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$55.43B
Dividend Yield0.53%
Average Volume (3M)1.10M
Price to Earnings (P/E)35.7
Beta (1Y)0.86
Revenue Growth12.66%
EPS Growth10.33%
CountryUS
Employees22,500
SectorIndustrials
Sector Strength72
IndustryElectrical Equipment & Parts
Share Statistics
EPS (TTM)6.87
Shares Outstanding229,261,250
10 Day Avg. Volume1,005,067
30 Day Avg. Volume1,099,612
Financial Highlights & Ratios
PEG Ratio4.05
Price to Book (P/B)4.45
Price to Sales (P/S)6.39
P/FCF Ratio28.31
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$281.82Price Target Upside14.93% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)8.31
Revenue Forecast (FY)$8.18B
Ametek Business Overview & Revenue Model
Company Description
AMETEK, Inc. is a global enterprise that develops and markets a diverse portfolio of electronic instruments and electromechanical devices. The company's operations are structured into two principal divisions: the Electronic Instruments Group (EIG)...
How the Company Makes Money
AMETEK makes money primarily by selling specialized, engineered products and systems through its two operating segments. (1) Electronic Instruments Group (EIG): Revenue is generated from the sale of electronic instruments and related solutions use...
Ametek Earnings Call Summary
Earnings Call Date:Aug 04, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 03, 2026
Earnings Call Sentiment Positive
The call was strongly positive: AMETEK reported record revenue, orders, backlog, margins, EBITDA and EPS, with very strong free cash flow, a raised full-year guide, robust segment-level performance (particularly EMG and EIG), active M&A execution and ongoing product innovation. The few negatives were largely execution and timing considerations tied to acquisitions (diligence costs, integration risk), some lumpiness in order cadence and conservative near-term guidance despite strong order trends. Overall, the positive operational, financial and strategic metrics substantially outweigh the limited lowlights.Positive Updates
Record Quarterly Revenue
Q2 sales of $2.04 billion, up 15% year-over-year; organic sales up 10% and acquisitions contributed ~5 points; foreign currency flat.
Negative Updates
Conservative Near-Term Revenue Outlook Despite Strong Orders
Management is guiding Q3 organic revenue to high single digits (deceleration vs. Q2) and built conservatism into the H2 guide despite exceptional order trends, reflecting caution on cadence and timing of recognition.
Read all updates
Q2-2026 Updates
Positive
Negative
Record Quarterly Revenue
Q2 sales of $2.04 billion, up 15% year-over-year; organic sales up 10% and acquisitions contributed ~5 points; foreign currency flat.
Read all positive updates
Company Guidance
AMETEK raised full‑year 2026 guidance, now expecting overall sales up ~10% (organic up mid‑ to high‑single digits) and diluted EPS of $8.20–$8.30 (≈+10–12% vs. prior year; prior guide $7.94–$8.14); for Q3 it projects sales up high‑single digits and adjusted EPS $2.08–$2.10 (≈+10–11% YoY). Key 2026 assumptions include an effective tax rate of 18.5–19%, capex ≈$160M (≈2% of sales), depreciation & amortization ≈$430M (including ~$210M of after‑tax acquisition‑related intangible amortization, ~$0.91 per share), and free cash flow conversion of 110–115% of net income. The company also expects to deploy ~$5.0B to acquire Indicor in H2 (leaving ~ $2.5B of cash/available credit pro forma); at June 30 debt was $2.0B with cash $495M (net debt ≈$1.5B) and gross/net debt‑to‑EBITDA of 0.8x/0.6x, and a renewed $3.5B revolver maturing June 2031.Ametek Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
88
Very Positive
Cash Flow
83
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.86B | 7.40B | 6.94B | 6.60B | 6.15B | 5.55B |
| Gross Profit | 2.88B | 2.69B | 2.48B | 2.38B | 2.15B | 1.91B |
| EBITDA | 2.42B | 2.30B | 2.16B | 2.03B | 1.83B | 1.60B |
| Net Income | 1.58B | 1.48B | 1.38B | 1.31B | 1.16B | 990.05M |
Balance Sheet | ||||||
| Total Assets | 16.59B | 16.07B | 14.63B | 15.02B | 12.43B | 11.90B |
| Cash, Cash Equivalents and Short-Term Investments | 495.45M | 457.95M | 374.00M | 409.80M | 345.39M | 346.77M |
| Total Debt | 2.31B | 2.34B | 2.32B | 3.37B | 2.56B | 2.72B |
| Total Liabilities | 5.33B | 5.44B | 4.98B | 6.29B | 4.95B | 5.03B |
| Stockholders Equity | 11.26B | 10.63B | 9.66B | 8.73B | 7.48B | 6.87B |
Cash Flow | ||||||
| Free Cash Flow | 1.82B | 1.67B | 1.70B | 1.60B | 1.01B | 1.05B |
| Operating Cash Flow | 1.96B | 1.80B | 1.83B | 1.74B | 1.15B | 1.16B |
| Investing Cash Flow | -1.39B | -1.06B | -244.81M | -2.38B | -552.76M | -2.06B |
| Financing Cash Flow | -685.02M | -686.32M | -1.60B | 697.28M | -575.70M | 39.34M |
Ametek Technical Analysis
Positive
245.20
Price Trends
241.38
Positive
235.28
Positive
224.15
Positive
Market Momentum
0.54
Positive
50.23
Neutral
25.84
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AME, the sentiment is Positive. The current price of 245.2 is below the 20-day moving average (MA) of 248.67, above the 50-day MA of 241.38, and above the 200-day MA of 224.15, indicating a neutral trend. The MACD of 0.54 indicates Positive momentum. The RSI at 50.23 is Neutral, neither overbought nor oversold. The STOCH value of 25.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AME.
Ametek Risk Analysis
Ametek disclosed 18 risk factors in its most recent earnings report. Ametek reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Ametek Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $55.43B | 35.69 | 14.55% | 0.54% | 12.66% | 10.33% | |
78 Outperform | $24.52B | 27.87 | 23.65% | 1.12% | 10.61% | 9.52% | |
77 Outperform | $24.52B | 42.07 | 15.76% | 0.55% | 46.19% | 3.13% | |
76 Outperform | $158.93B | 42.54 | 19.56% | 1.06% | 15.53% | -1.21% | |
74 Outperform | $6.93B | 36.52 | 27.51% | 0.15% | 7.04% | 8.18% | |
70 Outperform | $98.46B | 58.37 | 42.11% | 0.08% | 26.23% | 111.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
* Industrials Sector Average
AME
Ametek
245.20
59.64
32.14%
ETN
Eaton
419.44
68.00
19.35%
HUBB
Hubbell B
472.46
31.98
7.26%
POWL
Powell Industries
191.75
101.52
112.51%
NVT
nVent Electric
155.23
63.27
68.79%
VRT
Vertiv Holdings
263.81
129.73
96.75%
Ametek Corporate Events
Business Operations and StrategyM&A Transactions
AMETEK Completes Acquisition of Indicor Instrumentation Portfolio
Positive
Aug 26, 2026
On August 26, 2026, AMETEK announced it had completed its previously disclosed all-cash acquisition of Indicor Instrumentation, a $5.0 billion portfolio of businesses that design and manufacture mission-critical solutions for demanding industrial ...
Business Operations and StrategyPrivate Placements and Financing
Ametek Expands Commercial Paper Program for Acquisition Funding
Positive
Aug 11, 2026
On August 7, 2026, AMETEK, Inc. raised the maximum principal amount of short-term unsecured commercial paper that can be outstanding under its commercial paper program from $2.3 billion to $3.5 billion. The company kept other material terms unchan...
Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
Ametek Secures New Credit Facilities for Indicor Acquisition
Positive
Jun 12, 2026
On June 9, 2026, Ametek amended and restated its revolving credit facility, expanding lender commitments from $2.3 billion to $3.5 billion and extending the maturity to June 9, 2031. The facility includes customary covenants tied to leverage and i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.